Will the new Merk antiviral pill negate the need for vaccine mandates?

"Really Quite Impressive" says Fauci

When many people decide if they want to take a vaccine, they will weigh the severity of the disease against the possibility of vaccine side effects. However, if one cheap, safe, and effective antiviral pill reduces the severity of the SARS2/Covid-19 in half, doesn’t that cut the argument for the vaccines in half.

Merk’s new pill molnupiravir, could receive FDA emergency use authorization within months.

Inline Feedbacks
View all comments